CompaniesByCap
ONCO
Onconetix Inc. (ONCO)
NASDAQ · Healthcare

Onconetix Inc. Revenue 2023–2025

Onconetix Inc. annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Onconetix Inc. revenue for the quarter ending March 31, 2026 was 21457, a 78.89% decrease year-over-year.
  • Onconetix Inc. revenue for the twelve months ending March 31, 2026 was 533232.
  • Onconetix Inc. annual revenue for 2025 was 815371, a 67.70% decrease from 2024.
  • Onconetix Inc. annual revenue for 2024 was 2.5 M, a 4217.31% increase from 2023.
  • Onconetix Inc. annual revenue for 2023 was 58465.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Onconetix Inc. (ONCO) — Frequently Asked Questions

Onconetix Inc. (ONCO) is a publicly traded US company. It has a market capitalization of $965,820.7. In fiscal 2025 it reported revenue of $815,371 and net income of -$14M. Explore ONCO's stock price, financial statements, earnings history, margins and key ratios below.

What is Onconetix Inc.'s market cap?

Onconetix Inc. (ONCO) has a market capitalization of $965,820.7.

What is the ONCO stock price?

ONCO trades at $1.03 (-1.90% on the day).

How much revenue does Onconetix Inc. make?

Onconetix Inc. reported revenue of $815,371 in fiscal 2025.

Is ONCO profitable?

In fiscal 2025, Onconetix Inc. reported net income of -$14M.